Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 4Triple Negative Breast Neoplasms 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Thyroid Cancer, Papillary 1Sarcoma, Endometrial Stromal 1Neoplasm Metastasis 1Liver Neoplasms 1Leukemia, Hairy Cell 1Duodenal Neoplasms 1Carcinoma, Lobular 1Carcinoma, Hepatocellular 1Anatomic Stage I Breast Cancer AJCC v8 1Agnosia 1Adrenocortical Adenoma 1Adenocarcinoma, Follicular 1

Interventions

obeticholic acid 1fludarabine 1apixaban 1aldesleukin 1X-Rays 1Tea 1Surgical Procedures, Operative 1Specimen Handling 1Rivaroxaban 1Phantoms, Imaging 1Pantoprazole 1Iopamidol 1Hydromorphone 1High-Energy Shock Waves 1Endoscopy, Gastrointestinal 1Dalteparin 1Cyclophosphamide 1Bupivacaine 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Duodenal Neoplasms × High-Energy Shock Waves × Clear all
NCT06411795 2026-02-03

Rectus Sheath Block With Liposomal Bupivacaine Versus Thoracic Epidural Analgesia for Pain Control Following Pancreatoduodenectomy

Masonic Cancer Center, University of Minnesota

Phase 2 Recruiting
78 enrolled
Gastrointestinal

Duodenal Neoplasms, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡